Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- SimVADIndependent statistical analysis of Use of Simulation to Improve VAD Self-management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03073005).
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Singapore Tympanostomy Tube Delivery System Study: Complete Statistical AnalysisIndependent statistical analysis of Singapore Tympanostomy Tube Delivery System Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046877).
- SINGLEComplete statistical analysis of the SINGLE phase 3 trial comparing dolutegravir plus abacavir/lamivudine with Atripla in HIV-1 infection, including the Week 48 primary endpoint, later virologic suppression analyses, CD4 outcomes, non-inferiority methodology,…
- Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919035).
- Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals: Complete Statistical AnalysisIndependent statistical analysis of Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Single Ascending Dose Study of AMG 570 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Ascending Dose Study of AMG 570 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02618967).
- Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes: primary endpoint results,…
- Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY: Complete Statistical AnalysisIndependent statistical analysis of Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05737433).
- Single Dose CHG Pharmacokinetic Study: Complete Statistical AnalysisIndependent statistical analysis of Single Dose CHG Pharmacokinetic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03331263).
- Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02493426).
- Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old…
- Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population: primary endpoint results, effect estimate with confidence interval,…
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): Complete Statistical AnalysisIndependent statistical analysis of Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01106287).
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Single Hormone Closed Loop Study With PDT Sensor: Complete Statistical AnalysisIndependent statistical analysis of Single Hormone Closed Loop Study With PDT Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528174).
- Single or Double-layer Uterine Closure Techniques: Complete Statistical AnalysisIndependent statistical analysis of Single or Double-layer Uterine Closure Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03629028).
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec: Complete Statistical AnalysisIndependent statistical analysis of Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery: Complete Statistical AnalysisIndependent statistical analysis of Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses: Complete Statistical AnalysisIndependent statistical analysis of Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites: Complete Statistical AnalysisIndependent statistical analysis of Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02172755).
- Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid: Complete Statistical AnalysisIndependent statistical analysis of Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Single-Dose Study of MT203: Complete Statistical AnalysisIndependent statistical analysis of Single-Dose Study of MT203: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354599).
- Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: Complete Statistical AnalysisIndependent statistical analysis of Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single-Session Extraoral PBM After Third Molar Extraction: Complete Statistical AnalysisIndependent statistical analysis of Single-Session Extraoral PBM After Third Molar Extraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07522918).
- Single-Sided Deafness in the Medicare Population: Complete Statistical AnalysisIndependent statistical analysis of Single-Sided Deafness in the Medicare Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05250414).
- Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites: Complete Statistical AnalysisIndependent statistical analysis of Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03340025).
- Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sintilimab in Cancer of Unknown Primary: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Cancer of Unknown Primary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05024968).
- Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SINUS-52Independent statistical analysis of Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898454).
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SIPPYIndependent statistical analysis of Study to Investigate the Potential of Probiotics in Yogurt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00492583).
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01420965).
- SIRIndependent statistical analysis of Sugar-replacement Sweeteners, and Blood Sugar Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01128829).
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00388362).
- Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…